全球糖尿病設備市場規模、佔有率、成長分析、類型、分銷管道 - 2023-2030 年產業預測

Global Diabetes Device Market Size, Share, Growth Analysis, By Type(BGM Device, Insulin Delivery Device), By Distribution Channels(Hospital Pharmacies, Retail Pharmacies) - Industry Forecast 2023-2030

出版日期: 2024年02月10日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年，全球糖尿病器材市場規模為290.1億美元，從2023年的314.2億美元成長到2031年的5.94億美元，預測期間（2024-2031年）複合年成長率為8.3%。預計將成長至6000萬美元。

由於久坐的生活方式和都市化的加快，全球疾病負擔正在增加。根據國際糖尿病聯盟的數據，年齡在 20 歲至 79 歲之間的約 5.3 億人被診斷出患有糖尿病。其他健康狀況也與此疾病有關，包括中風、心血管疾病、神經病變和感染疾病。隨著疾病管理和併發症預防意識的提高，糖尿病醫療設備的發展預計將加速。先進的胰島素幫浦、筆和其他糖尿病設備創新的推出正在推動對這些產品的需求。領先的製造商專注於技術進步並開發尖端產品，以佔領很大一部分市場。

使用自上而下和自下而上的方法來預測和檢驗糖尿病設備的全球市場規模，並預測其他各個相關子市場的市場規模。用於估計市場規模的調查方法包括以下細節：透過二次研究確定市場的主要企業，並透過初步和二次研究確定每個地區的市場佔有率。整個過程包括研究主要企業的年度報告和財務報告，以及廣泛的採訪，以獲取首席執行官、副總裁、董事和行銷負責人等行業領導者的關鍵見解。馬蘇。所有股份比率和細分均使用二手資訊確定並使用主要資訊檢驗。本研究涵蓋的所有可能影響市場的參數都經過了考慮、詳細研究、初步研究檢驗和分析，以獲得最終的定量和定性資料。

全球糖尿病設備細分市場分析

全球糖尿病設備市場根據類型、分銷管道和地區進行細分。按類型分類，市場分為 BGM 設備、胰島素輸送設備和連續血糖監測設備。從市場區隔來看，市場分為醫院藥局、零售藥局、糖尿病診所、網路藥局。按地區分類，市場分為北美、歐洲、亞太地區、中東和非洲以及拉丁美洲。

全球糖尿病設備市場的促進因素

全球範圍內糖尿病發生率的上升是推動糖尿病設備市場成長的關鍵因素。久坐的生活方式、不良的飲食習慣、肥胖和人口老化等因素導致糖尿病發生率上升。隨著越來越多的人被診斷出患有糖尿病，對糖尿病設備的需求不斷成長，以有效管理和監測他們的糖尿病狀況。

定期自我監測血糖值在糖尿病管理中發揮重要作用。可攜式、使用者友善型血糖值監測設備的日益普及正在加速患者的接受度。自我血糖監測使個人能夠持續追蹤血糖值，就胰島素劑量和用餐選擇做出明智的決定，並有效管理糖尿病。

全球糖尿病器材市場的限制因素

糖尿病設備的準確性和可靠性是成功管理糖尿病的基礎。然而，根據儀器的不同，測量結果可能會有所不同，可能會出現校準問題或技術故障，進而影響資料的可靠性。不準確的測量可能會導致錯誤的治療選擇並威脅患者的健康。確保糖尿病設備的準確性和可靠性對於建立醫療保健專業人員和糖尿病管理個人的信任至關重要。

全球糖尿病設備市場趨勢

胰島素幫浦和筆等胰島素輸送系統不斷進步，具有更複雜的功能和連接性。市場正在看到智慧胰島素輸送系統的趨勢，該系統與連續血糖監測 (CGM) 系統同步，並能夠根據血糖讀數自動調整胰島素。此類系統提高了便利性、準確性和客製化的胰島素輸送，以增強血糖控制。

執行摘要
調查方法
母市場分析
主要市場考察
- 技術分析
- 價格分析
- 供應鏈分析
- 價值鏈分析
- 市場生態系統
- 智慧財產權分析
- 貿易分析
- Start-Ups分析
- 原料分析
- 創新矩陣
- 研發線產品分析
- 總體經濟指標
- 主要投資分析
- 關鍵成功因素
- 競爭程度
市場動態及展望
- 市場動態
  - 促進因素
  - 機會
  - 抑制因素
  - 任務
- 監管形勢
- 波特的分析
- 對未來中斷的特殊考慮
全球糖尿病設備市場：按類型
- 市場概況
- 背景音樂裝置
- 胰島素給藥裝置
- 連續血糖監測
全球糖尿病設備市場：按分銷管道分類
- 市場概況
- 醫院藥房
- 零售藥房
- 糖尿病診所
- 網路藥房
全球糖尿病設備市場規模：按地區分類
- 市場概況
- 北美洲
  - 美國
  - 加拿大
- 歐洲
  - 德國
  - 西班牙
  - 法國
  - 英國
  - 其他歐洲國家地區
- 亞太地區
  - 中國
  - 印度
  - 日本
  - 韓國
  - 其他亞太地區
- 拉丁美洲
  - 巴西
  - 其他拉丁美洲地區
- 中東和非洲 (MEA)
  - 海灣合作理事會國家
  - 南非
  - 其他中東/非洲地區
競爭形勢
- 前5名企業對比
- 主要企業市場定位（2021年）
- 主要市場參與者所採取的策略
- 關鍵成功策略
- 近期市集活動
- 主要企業市場佔有率（2021年）
主要企業簡介
- Medtronic（United States）
- Roche（Switzerland）
- Johnson & Johnson（United States）
- Abbott Laboratories（United States）
- Becton, Dickinson and Company（United States）
- Novo Nordisk（Denmark）
- Dexcom（United States）
- Sanofi（France）
- Insulet Corporation（United States）
- Ascensia Diabetes Care Holdings AG（Switzerland）
- Ypsomed Holding AG（Switzerland）
- Eli Lilly and Company（United States）
- LifeScan（United States）
- Tandem Diabetes Care（United States）
- Terumo Corporation（Japan）
- Arkray（Japan）
- Senseonics Holdings, Inc.（United States）
- MicroPort Scientific Corporation（China）
- Nipro Corporation（Japan）
- Sinocare Inc.（China）
- AgaMatrix Holdings LLC（United States）
- Trividia Health, Inc.（United States）

簡介目錄

Product Code: SQMIG35B2125

Global Diabetes Device Market size was valued at USD 29.01 Billion in 2022 and is poised to grow from USD 31.42 Billion in 2023 to USD 59.46 Billion by 2031, at a CAGR of 8.3% during the forecast period (2024-2031).

The global burden of illness is on the rise due to the adoption of sedentary lifestyles and increasing urbanization. According to the International Diabetes Federation, approximately 530 million individuals aged 20 to 79 have been diagnosed with diabetes. Other health conditions such as stroke, cardiovascular issues, nerve damage, and infections are also linked to this disease. As awareness of disease management and prevention of complications grows, the development of diabetes medical devices is expected to accelerate. The introduction of advanced insulin pumps, pens, and other technological innovations in diabetic devices is fuelling the demand for these products. Leading manufacturers are focusing on technological advancements and the creation of state-of-the-art products to capture a significant portion of the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetes Device Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Diabetes Device Market Segmental Analysis

Global Diabetes Device Market is segmented on the basis of type, distribution channels and region. By type, the market is segmented into BGM device, insulin delivery device, continuous glucose monitoring. By distribution channels, the market is segmented into hospital pharmacies, retail pharmacies, diabetes clinics, online pharmacies. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Diabetes Device Market

The increasing occurrence of diabetes on a global scale is a key factor propelling the growth of the diabetes device market. Factors like sedentary lifestyles, poor dietary patterns, obesity, and an aging populace are among the contributors to the escalating incidence of diabetes. With a rising number of individuals diagnosed with diabetes, there emerges an elevated need for diabetes devices to effectively manage and monitor the condition.

Regular self-monitoring of blood glucose levels plays a vital role in diabetes management. The accessibility of portable and user-friendly blood glucose monitoring devices has spurred higher acceptance among patients. Self-monitoring empowers individuals to consistently track their blood glucose levels, make informed decisions regarding insulin dosage and dietary selections, and effectively manage their diabetes.

Restraints in the Global Diabetes Device Market

The precision and dependability of diabetes devices are fundamental for successful diabetes management. Nevertheless, certain devices may demonstrate disparities in measurements, calibration challenges, or technical malfunctions, which could affect the reliability of data. Inaccurate readings have the potential to result in erroneous treatment choices and jeopardize patient well-being. Guaranteeing the precision and dependability of diabetes devices is vital for establishing confidence among healthcare practitioners and individuals managing diabetes.

Market Trends of the Global Diabetes Device Market

Insulin delivery systems, such as insulin pumps and pens, are continuously advancing with more sophisticated functionalities and connectivity capabilities. There is a trend in the market towards intelligent insulin delivery systems that synchronize with Continuous Glucose Monitoring (CGM) systems, enabling automatic insulin adjustments according to glucose readings. These systems provide increased convenience, accuracy, and tailored insulin delivery, thereby enhancing glycaemic management.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
  - Drivers
  - Opportunities
  - Restraints
  - Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
  - Drivers
  - Opportunities
  - Restraints
  - Challenges
- Regulatory Landscape
- Porters Analysis
  - Competitive rivalry
  - Threat of Substitute Products
  - Bargaining Power of Buyers
  - Threat of New Entrants
  - Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
  - Political Impact
  - Economic Impact
  - Social Impact
  - Technical Impact
  - Environmental Impact
  - Legal Impact
Global Diabetes Device Market by Type
- Market Overview
- BGM Device
- Insulin Delivery Device
- Continuous Glucose Monitoring
Global Diabetes Device Market by Distribution Channels
- Market Overview
- Hospital Pharmacies
- Retail Pharmacies
- Diabetes Clinics
- Online Pharmacies
Global Diabetes Device Market Size by Region
- Market Overview
- North America
  - USA
  - Canada
- Europe
  - Germany
  - Spain
  - France
  - UK
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - South Korea
  - Rest of Asia-Pacific
- Latin America
  - Brazil
  - Rest of Latin America
- Middle East & Africa (MEA)
  - GCC Countries
  - South Africa
  - Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
  - By Development
  - By Company
  - By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Medtronic (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Roche (Switzerland)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Johnson & Johnson (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Abbott Laboratories (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Becton, Dickinson and Company (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Novo Nordisk (Denmark)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Dexcom (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Sanofi (France)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Insulet Corporation (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Ascensia Diabetes Care Holdings AG (Switzerland)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Ypsomed Holding AG (Switzerland)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Eli Lilly and Company (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- LifeScan (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Tandem Diabetes Care (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Terumo Corporation (Japan)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Arkray (Japan)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Senseonics Holdings, Inc. (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- MicroPort Scientific Corporation (China)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Nipro Corporation (Japan)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Sinocare Inc. (China)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- AgaMatrix Holdings LLC (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Trividia Health, Inc. (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments